Synapse - Find an Expert

2442 Results

Oncocytic pancreatic endocrine neoplasms: A clinicopathologic and immunohistochemical analysis of 21 cases

Meeting Abstract

Hussain, S.; Arwini, A.; Chetty, R.; Klimstra, D. S.
Laboratory Investigation (2005)

Fulltext@MSK | Save

Effect of adjuvant chemotherapy (CRx) on the cognitive function of older patients (pts) with breast cancer (BC): Results from a prospective study

Meeting Abstract

Hurria, A.; Rosen, C.; Zuckerman, E.; Holland, J.; Panageas, K.; Witmer, M.; van Gorp, W.; Norton, L.; Hudis, C.
Journal of Clinical Oncology (2005)

Fulltext@MSK | Save

A prospective longitudinal study of the impact of adjuvant chemotherapy for breast cancer (BC) on older patients' functional status and quality of life

Meeting Abstract

Hurria, A.; Panageas, K.; Zuckerman, E.; Fornier, M.; D'Andrea, G.; Dang, C.; Moasser, M.; Robson, M.; Seidman, A.; Currie, V.; more...
Breast Cancer Research and Treatment (2005)

Fulltext@MSK | Save

Five year follow-up of INT C9741: Dose-dense (DD) chemotherapy (CRx) is safe and effective

Meeting Abstract

Hudis, C.; Citron, M.; Berry, D.; Cirrincione, C.; Gradishar, W.; Davidson, N.; Martino, S.; Livingston, R.; Ingle, J.; Perez, E.; more...
Breast Cancer Research and Treatment (2005)

Fulltext@MSK | Save

Missing killer immunoglobulin-like receptor (KIR) ligand confers protection from relapse in recipients of unrelated hematopoietic cell transplantation (HCT) for AML

Meeting Abstract

Hsu, K. C.; Malkki, M.; Gooley, T. A.; Dupont, B.; Petersdorf, E. W.
Biology of Blood and Marrow Transplantation (2005)

Fulltext@MSK | Save

Lack of HLA-C group 2 KIR ligand in the recipient predictive of lower relapse and higher overall survival in unrelated transplants

Meeting Abstract

Hsu, K. C.; Malkki, M.; Gooley, T.; Pinto-Agnello, C.; Dupont, B.; Petersdorf, E.
Tissue Antigens (2005)

Fulltext@MSK | Save

Population pharmacokinetic (PK)-pharmacodynamic (PD) meta-analysis of sunitinib malate (SU11248) efficacy and tolerability endpoints in gastrointestinal stromal tumor (GIST), metastatic renal cell carcinoma (MRCC) and solid tumor patients

Meeting Abstract

Houk, B. E.; Bello, C.; Garrett, M.; Poland, B.; Wagg, J.; Wada, R.; Motzer, R.; Rosen, L.; Demetri, G.
Clinical Cancer Research (2005)

Fulltext@MSK | Save

Second-line therapy with ICE followed by high dose therapy and autologous stem cell transplantation for relapsed/refractory peripheral T-Cell lymphomas: Minimal benefit when analyzed by intent to treat